Antiphospholipid Syndrome: Not All Antibodies Are Created Equal
Nicola Pozzi, Associate Professor of Thrombosis and Hemostasis and Autoimmunity at Saint Louis University School of Medicine, shared a post on LinkedIn:
”Antiphospholipid Syndrome (APS) isn’t a one-size-fits-all disease—and neither are antiphospholipid antibodies.
In our latest work, led by Suresh Kumar, we advance understanding of the molecular complexity behind pathogenic antibodies targeting β2GPI and, in doing so, we introduce new concepts and tools that may help achieve more personalized diagnostic strategies and accelerate the development of neutralization approaches.
Our goal of building an Antiphospholipid Antibody Atlas to fight APS continues… Just keep watching APS…Just keep watching…”
For more information
Find More Posts on Hemostasis Today.
-
Nov 2, 2026, 11:46William McKeown: Advancing Gene and Cell Therapies for Inherited Bleeding Disorders
-
Nov 2, 2026, 11:41Anawat Ratchatorn: Identifying Stroke Mimics in the Emergency Department
-
Nov 2, 2026, 11:29Shruti Gadgil: AI-Powered Smartphone Screening for Anemia Severity in Rural India
-
Nov 2, 2026, 10:41Paulus Kirchhof: Smoking or Vaping – Nicotine Still Affects Vascular Health
-
Nov 2, 2026, 10:30Asesa Omullo: Connecting Sickle Cell Advocates at GANSID 2026
-
Nov 2, 2026, 10:18Salih Ehsan: Beyond IRIDA – Conditions That Mimic Iron-Refractory Anemia
-
Nov 2, 2026, 10:03Christian Heiss: Can Switching to E-Cigarettes Improve Vascular Health?
-
Nov 2, 2026, 09:56Priya Prasad: Safe Blood Begins with Informed Choices
-
Nov 2, 2026, 09:43Moath Ahmad Albliwi: More Than 10 Abstracts Accepted for ASH 2026